Alloy and Biogen Partner on Antisense Drug Platform
BOSTON, Massachusetts, United States, April 7, 2026 Alloy Therapeutics Inc. announced a multi-target collaboration and license agreement with Biogen...
biotech collaboration
Advertisement
Quotient Therapeutics, Merck Sign $2.2B IBD Deal
CAMBRIDGE, MASSACHUSETTS, March 24, 2026 Quotient Therapeutics has announced a multi-year research collaboration with Merck & Co. to discover...
Voro Therapeutics Partners with Daiichi Sankyo on ADCs
SAN DIEGO, CA, March 17, 2026 Voro Therapeutics has announced a research collaboration with Daiichi Sankyo to advance its...
Tenaya–Alnylam $1.13B Deal Targets Heart Disease Genes
South San Francisco, California — March 5, 2026 Tenaya Therapeutics and Alnylam Pharmaceuticals have announced a major research collaboration...
Janux and BMS Partner on Tumor-Activated Cancer Therapy
SAN DIEGO, January 22, 2026 — Janux Therapeutics announced a collaboration and exclusive worldwide license agreement with Bristol Myers...
Advertisements
HOOKIPA Completes Sale of HBV and HIV Programs to Gilead Sciences
NEW YORK and VIENNA – October 31, 2025 — HOOKIPA Pharma Inc. (OTC: HOOK) announced the completion of the...
Advertisement
